
ACRP, Certified Clinical Research Associate
IQVIA Global Mentor of the Year, 2013
Janux Therapeutics Inc.
Phase 1 Oncology (Advanced Solid Tumors)
Phase 1 Autoimmune
Nuvation Bio, Inc
Phase 1 Oncology (Advanced Solid Tumors)
Adamas Pharmaceuticals, Inc.
Phase III Multiple Sclerosis, Parkinson's Disease
Myovant Sciences, Inc.
Phase III Endometriosis- Associated Pain
Medivation, Inc.
Phase I-IV Oncology (Prostate, Breast, DLBCL, Diffuse Intrinsic Pontine Glioma)
IQVIA / Amgen
Phase I–IV Oncology/Hematology (SCLC, NSCLC, Pancreatic, Breast, Ovarian, Ewing’s Sarcoma, DRCT, Head and Neck, Prostate, Soft Tissue Sarcoma, Gastric and Esophageal, Giant Cell Tumor, ALL, AML, CML, CLL)
Phase I Systemic Lupus Erythematosus
Phase III Myelodysplastic Syndrome, Idiopathic Thrombocytopenic Purpura
Phase IV End Stage Renal Disease
ChemoCentryx, Inc.
Phase 1 CNS
Phase II Crohn’s Disease, Celiac Disease
AstraZeneca Pharmaceuticals
Phase II-III Oncology (NSCLC, Breast, Prostate, Thyroid)
Phase II-III Cardiology (Type II Diabetes, Hyperlipidemia, Acute Coronary Syndrome, and Congestive Heart Failure)
Phase III CNS (Schizophrenia, Bi-polar Disorder)
Scios, Inc.
Phase II-III Cardiology (Congestive Heart Failure)
University of California, San Francisco
HIV/AIDS early infection trial for pathology, immunology, virology
HIV/AIDS serodiscordant couples and cross-infection
HIV/AIDS positive couples / cross-infection of resistant strains
HIV/AIDS treatment interruption therapies and IL-2
Phase 1 HIV vaccine trials